Oxalic Acid

Oxalic Acid

SCHEMBL4386146

Fc1ccc(C(CCCN2CCC(=NOc3ccccc3)CC2)c2ccc(F)cc2)cc1.O=C(O)C(=O)O

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 7/20 0.51
SLC6A4 known ✓ P31645 3/20 0.47
HTR2A P28223 8/20 0.51
ADRA1A P35348 8/20 0.51
HRH1 P35367 8/20 0.51
DRD3 P35462 8/20 0.51
SLC6A3 Q01959 8/20 0.51
OPRK1 P41145 7/20 0.51
HTR6 P50406 7/20 0.51
CACNA1C Q13936 7/20 0.51
CACNA1F O60840 6/20 0.51
HRH2 P25021 6/20 0.51
CACNA1D Q01668 6/20 0.51
CACNA1S Q13698 6/20 0.51
OPRD1 P41143 6/20 0.51
DRD5 P21918 5/20 0.51
ADRA1D P25100 5/20 0.51
HTR7 P34969 5/20 0.51
ADRA1B P35368 5/20 0.51
DRD4 P21917 5/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13588936 0.94 SLC6A3 (0.47) HTR2AADRA1AHRH1DRD3SLC6A3
Oxalic Acid SCHEMBL4380546 0.85 SLC6A3 (0.54) HTR2AADRA1AHRH1DRD3SLC6A3
Oxalic Acid SCHEMBL4391692 0.84 SLC6A3 (0.57) HTR2AADRA1AHRH1DRD3SLC6A3
SCHEMBL8225045 0.79 SLC6A3 (0.51) HTR2AADRA1AHRH1DRD3SLC6A3
Oxalic Acid SCHEMBL4382481 0.79 DRD3 (0.49) HTR2AADRA1AHRH1DRD3SLC6A3
SCHEMBL13588937 0.77 SLC6A3 (0.54) HTR2AADRA1AHRH1DRD3SLC6A3
Oxalic Acid SCHEMBL4380272 0.77 HTR2A (0.48) HTR2AADRA1AHRH1DRD3SLC6A3
Oxalic Acid SCHEMBL4395310 0.77 TACR1 (0.46) HTR2AADRA1AHRH1DRD3SLC6A3
SCHEMBL7295696 0.75 SCN5A (0.58) HTR2AADRA1AHRH1DRD3SLC6A3
SCHEMBL4752728 0.74 CACNA1F (0.67) HTR2AADRA1AHRH1DRD3SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298878-A1 OXIME COMPOUNDS AND THE USE THEREOF PURDUE PHARMA L.P. 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298878-A1 OXIME COMPOUNDS AND THE USE THEREOF KCNN4, CACNA1A, KCNN3 OPRM1 55/4885SLC6A4 446/4885HTR2A 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.